{"doc_key": "sents_AND_False", "dataset": "ace05", "sentences": [["It", "is", "certainly", "true", "and", "well", "known", "that", "several", "patients", "discharged", "from", "ICU", ",", "thus", "also", "several", "COVID", "19", "patients", ",", "suffer", "of", "chronic", "illness", "myopathy", "or", "neuropathy", "or", "both", "which", "might", "worsen", "the", "clinical", "outcomes", "."], ["Second", ",", "the", "rate", "of", "severe", "secondary", "infectionsa", "possible", "major", "safety", "concern", "which", "might", "be", "expected", "during", "IL-6-blocking", "treatmentswas", "not", "increased", "in", "sarilumab-treated", "patients", "as", "compared", "with", "those", "receiving", "standard", "of", "care", "."], ["However", ",", "these", "findings", "must", "be", "carefully", "interpreted", "because", "lowered", "NK", "cell", "populations", "are", "occasionally", "associated", "with", "lowered", "NK", "cell", "cytotoxicity", "."], ["Studies", "have", "shown", "that", "a", "diet", "containing", "reduced", "saturated", "fat", "and", "cholesterol", "led", "to", "manipulation", "of", "lipid", "metabolism", "in", "monkeys", ",", "which", "in", "turn", "provided", "significant", "benefits", "by", "slowing", "down", "simian", "immunodeficiency", "virus", "disease", "progression", "69", "."], ["On", "it", "we", "can", "see", "the", "similarities", "between", "the", "densities", "of", "these", "three", "values", "of", "course", "the", "MinKL", "density", "is", "a", "bit", "biased", "to", "the", "left", "and", "MaxKL", "density", "to", "the", "right", ",", "being", "the", "Bayesian", "density", "in", "the", "middle", ",", "but", "with", "very", "small", "differences", "."], ["Major", "changes", "in", "the", "diagnosis", "of", "viral", "infections", "occurred", "in", "the", "1990s", ",", "with", "the", "advent", "of", "more", "sensitive", "molecular", "techniques", ",", "such", "as", "enzymelinked", "immunosorbent", "assays", "ELISAs", "and", "polymerase", "chain", "reaction", "PCR", "in", "particular", "."], ["Moreover", ",", "incorporation", "of", "two", "host", "proteins", "in", "purified", "virions", "was", "verified", "by", "Western", "blot", "analysis", "using", "available", "immunological", "reagents", "."], ["Establishment", "of", "a", "course", "in", "a", "relatively", "unexplored", "field", "such", "as", "this", "offers", "particularly", "attractive", "possibilities", "for", "maximizing", "the", "potential", "of", "the", "relationship", "between", "teaching", "and", "research", "."], ["IFN-", "in", "conjunction", "with", "corticosteroids", "were", "shown", "to", "improve", "oxygen", "saturation", "and", "facilitate", "more", "rapid", "resolution", "of", "radiographic", "lung", "abnormalities", "in", "SARS", "infection", "Loutfy", "et", "al.", ",", "2003", "."], ["It", "was", "harming", "ASEAN", "in", "two", "ways", "The", "USA", "is", "one", "of", "the", "largest", "destination", "markets", "and", "Mexico", "is", "one", "of", "the", "lead", "competitors", "for", "ASEAN", "products", "."], ["Bound", "to", "the", "viral", "capsid", ",", "antibodies", "mediate", "sequestration", "by", "Fc", "receptor", "FcR-positive", "cells", "including", "DCs", "40", ",", "neutrophils", "41", ",", "and", "tissue-resident", "macrophages", "42", ",", "resulting", "in", "vector", "clearance", "and", "poor", "tissue", "transduction", "."], ["The", "relatively", "high", "prevalence", "of", "informal", "wage", "employment", "points", "to", "the", "significance", "of", "informal", "wage", "employment", "in", "formal", "firms", "and", "for", "households", ",", "not", "just", "in", "informal", "enterprises", "."], ["At", "low", "force", "10", "pN", ",", "the", "force-", "extension", "curve", "FEC", "showed", "monotonic", "extension", "of", "the", "DNARNA", "handles", "Figure", "2A", "and", "Figure", "2figure", "supplement", "2", ",", "indicating", "that", "a", "single", "molecule", "was", "being", "stretched", "."], ["Whites", "are", "more", "likely", "than", "Blacks", ",", "and", "Blacks", "more", "likely", "than", "Hispanics", ",", "to", "have", "a", "private", "insurance", "supplement", "to", "Medicare", "."], ["This", "is", "despite", "the", "fact", "that", ",", "for", "this", "application", ",", "Kuai", "employs", "the", "unrealistic", "optimisation", "where", "the", "barrier", "transition", "forces", "the", "immediate", "update", "of", "the", "forwarding", "state", "."], ["For", "these", "reasons", ",", "it", "is", "necessary", "to", "actively", "use", "the", "technology", "of", "value", "screening", ",", "aimed", "at", "conducting", "advanced", "diagnostics", "of", "the", "value", "system", "of", "employees", "in", "order", "to", "identify", "prerequisites", "for", "the", "development", "of", "value", "distortions", "."], ["We", "found", "sequences", "collected", "from", "late", "February", "to", "early", "March", "in", "Noord", "Brabant", ",", "Limburg", ",", "Utrecht", "as", "well", "as", "Zuid", "Holland", "spread", "around", "the", "tree", "indicating", "genetically", "very", "diverse", "strains", "Fig.", "8", "."], ["Secreted", "IFNs", "circulate", "in", "the", "body", "and", "cause", "susceptible", "cells", "to", "express", "potent", "antiviral", "mechanisms", "which", "limit", "further", "viral", "growth", "and", "spread", "."], ["A", "study", "conducted", "by", "Liu", "and", "colleagues", "demonstrated", "that", "25-HC", "induces", "cellular", "membrane", "modifications", "resulting", "in", "impaired", "viral", "entry", "during", "virus-cell", "fusion", "38", "."], ["Antibody", "purification", "from", "plants", "can", "be", "achieved", "with", "existing", "methods", "."], ["A", "unique", "feature", "of", "these", "viruses", "is", "the", "ability", "to", "mutate", "rapidly", "and", "adapt", "to", "a", "new", "host", "."], ["Added", "routinely", "to", "the", "feed", "of", "livestock", "and", "poultry", ",", "these", "enzymes", "are", "efficient", "at", "maximizing", "feed", "conversion", "efficiency", ",", "and", "more", "importantly", "they", "have", "no", "or", "very", "few", "side", "effects", "."], ["The", "model", "we", "develop", "is", "a", "noisy", "rational", "expectation", "equilibrium", "model", " ", "la", "Grossman", "and", "Stiglitz", "1980", "in", "which", "competitive", "price-taking", ",", "loss-averse", "speculators", "endowed", "with", "private", "information", "maximize", "their", "expected", "utility", ",", "trading", "with", "liquidity", "traders", "and", "risk-neutral", "uninformed", "market", "makers", "MMs", "."], ["By", "means", "of", "a", "proof-of-principle", "we", "provide", "an", "overview", "of", "the", "possibility", "and", "successful", "unique", "introduction", "of", "a", "so-called", "professional", "hybrid", "production", "in", "a", "micro", "factory", "using", "3D-printing", "at", "the", "place", "of", "greatest", "demand", "in", "a", "hospital", "by", "medical", "personnel", "to", "produce", "their", "own", "PPE", "."], ["To", "avoid", "this", "pitfall", ",", "we", "have", "chosen", "not", "to", "enter", "into", "this", "logic", "and", "to", "consider", "the", "media", "production", "studied", "as", "a", "field", "of", "heterogeneous", "communicative", "action", "a", "habermasian", "perspective", "."], ["Acute", "macroglossia", "is", "an", "uncommon", "and", "perplexing", "clinical", "problem", "."], ["As", "the", "number", "of", "people", "protected", "or", "of", "concern", "by", "UNHCR", "has", "reached", "record", "highs", ",", "its", "annual", "budget", "has", "likewise", "jumped", "several", "fold", "in", "just", "a", "few", "years", "."], ["It", "is", "essential", "that", "wasteful", "or", "inconsistent", "delivery", "of", "aerosolized", "emerging", "drugs", "or", "biological", "therapies", "be", "minimized", "so", "that", "the", "full", "promise", "of", "these", "expensively", "developed", "therapies", "is", "realized", "in", "clinical", "trials", "."], ["The", "Point-Of-Use", "Quality", "Assurance", "POUQA", "tool", "presented", "in", "this", "study", "has", "been", "rapidly", "developed", "as", "a", "response", "to", "this", "need", ",", "extending", "existing", "work", "in", "pathology", "and", "radiology", "quality", "assurance", "tools.1112", "It", "is", "because", "the", "recovery", "speed", "of", "the", "sensors", "is", "slower", "than", "their", "response", "speed", ",", "some", "water", "molecules", "are", "accumulated", "on", "the", "sensitive", "materials", "during", "the", "recovery", "process", ",", "leading", "to", "unbalanced", "water", "adsorption", "and", "desorption", "cycles", "and", "gradually", "increased", "current", "baseline", "."], ["Before", "these", "close", "contacts", "were", "transferred", "to", "the", "isolation", "ward", ",", "we", "evaluated", "the", "severity", "of", "their", "psychotic", "symptoms", ",", "depression", "symptoms", ",", "anxiety", "symptoms", ",", "psychological", "stress", ",", "and", "sleep", "quality", "."], ["However", ",", "all", "the", "techniques", "available", "have", "benefits", "and", "disadvantages", ",", "and", "their", "complementary", "natures", "mean", "that", "there", "are", "advantages", "to", "be", "gained", "by", "using", "them", "in", "combination", "."], ["To", "ensure", "that", "resistance", "does", "subside", ",", "surveillance", "should", "be", "used", "as", "an", "active", ",", "rather", "than", "a", "passive", ",", "method", "to", "track", "the", "frequency", "of", "resistant", "viruses", "in", "real", "time", ",", "and", "not", "retrospectively", "."], ["We", "first", "excluded", "from", "the", "analysis", "all", "invalid", "answers", ",", "as", "non-serious", "responses", "may", "have", "been", "provided", "by", "individuals", "who", "participated", "in", "the", "survey", "just", "for", "reward", "."], ["Patients", "with", "intensive", "nurse-led", "rehabilitation", "had", "the", "same", "outcomes", "as", "the", "control", "groups", ",", "but", "overall", "felt", "they", "had", "received", "a", "better", "service", "and", "had", "a", "point", "of", "contact", "for", "problems", "after", "discharge", "."], ["As", "such", ",", "there", "are", "limited", "usage", "statistics", "available", "."], ["A", "special", "value", "denotes", "unlimited", "continuous", "blinking", "."], ["Conversely", ",", "serotype", "II", "FIPV", "can", "only", "enter", "cells", "expressing", "feline", "APN", "Tresnan", "and", "Holmes", ",", "1998", "."], ["Taken", "together", ",", "these", "results", "point", "to", "a", "function", "of", "DC-SIGN", "as", "an", "attachment", "factor", "and", "not", "a", "receptor", "for", "filoviruses", "."], ["Twenty", "of", "those", "21", "patients", "recovered", "and", "were", "discharged", "within", "2", "weeks", "after", "tocilizumab", "therapy", ",", "with", "no", "adverse", "drug", "events", "."], ["It", "is", "important", "to", "note", "that", "available", "endogenous", "protein", "structures", "are", "biased", "towards", "permanent", ",", "rather", "than", "transient", "interactions", "."]], "predicted_ner": [[[9, 9, "PER", 17.3973, 1.0], [12, 12, "ORG", 15.6289, 1.0], [17, 18, "PER", 1.3559, 0.7016], [19, 19, "PER", 18.289, 1.0]], [[60, 60, "PER", 12.1388, 1.0], [64, 64, "PER", 13.1372, 1.0]], [[82, 82, "LOC", 5.2994, 0.7117]], [], [[131, 131, "PER", 9.5606, 0.9976], [164, 164, "LOC", 4.9382, 0.9904]], [], [[217, 217, "LOC", 0.6142, 0.6388]], [[241, 241, "LOC", 21.6571, 1.0], [244, 244, "LOC", 16.1687, 1.0]], [[284, 285, "ORG", 0.6632, 0.6509]], [[293, 293, "GPE", 12.6954, 1.0], [298, 298, "GPE", 21.5507, 1.0], [300, 300, "GPE", 17.9718, 1.0], [305, 305, "GPE", 10.6119, 1.0], [307, 307, "GPE", 26.419, 1.0], [309, 309, "GPE", 19.9127, 1.0], [313, 313, "GPE", 19.461, 1.0], [315, 315, "GPE", 14.5059, 1.0]], [], [[371, 371, "ORG", 9.7948, 0.9999], [380, 380, "ORG", 11.2524, 1.0]], [[392, 392, "ORG", 12.5952, 1.0], [398, 398, "ORG", 1.3667, 0.7932], [412, 412, "WEA", 0.92, 0.5195]], [[417, 417, "PER", 16.9231, 1.0], [422, 422, "PER", 22.7179, 1.0], [425, 425, "PER", 21.5612, 1.0], [429, 429, "PER", 14.6673, 1.0], [438, 438, "ORG", 11.6234, 1.0]], [[451, 451, "GPE", 15.6536, 1.0], [458, 458, "VEH", 7.7878, 0.9996], [467, 467, "GPE", 18.8461, 1.0]], [[495, 495, "PER", 18.6372, 1.0]], [[508, 508, "PER", 4.0172, 0.8829], [519, 520, "GPE", 10.5674, 0.9999], [522, 522, "GPE", 16.8584, 1.0], [524, 524, "GPE", 15.7968, 1.0], [528, 529, "GPE", 0.4886, 0.5147]], [[547, 547, "PER", 0.7438, 0.6113]], [[569, 569, "PER", 31.7159, 1.0], [571, 571, "PER", 22.5255, 1.0]], [[592, 592, "FAC", 21.1303, 1.0]], [[617, 617, "LOC", 3.444, 0.9483]], [], [[653, 653, "PER", 6.9037, 0.9854], [664, 664, "PER", 1.9103, 0.8685], [666, 666, "PER", 6.3812, 0.9983], [674, 674, "PER", 12.2979, 1.0], [680, 680, "PER", 7.4781, 0.9755], [687, 687, "PER", 11.9044, 1.0], [692, 692, "PER", 5.6521, 0.961]], [[700, 700, "ORG", 4.0515, 0.7456], [720, 720, "FAC", 3.7872, 0.8499], [725, 725, "FAC", 7.8046, 0.9995], [731, 731, "FAC", 15.5059, 1.0], [734, 734, "PER", 12.6315, 1.0], [737, 737, "PER", 17.5394, 1.0], [738, 738, "PER", 0.0876, 0.4987]], [[746, 746, "GPE", 3.7979, 0.6552]], [], [[787, 787, "PER", 14.0915, 1.0], [793, 793, "ORG", 23.7807, 1.0], [799, 799, "ORG", 19.0948, 1.0]], [], [], [[932, 932, "PER", 10.9062, 0.9999], [937, 937, "PER", 12.2204, 1.0]], [], [], [[1019, 1019, "PER", 3.396, 0.7656], [1037, 1037, "PER", 10.5182, 0.9998], [1038, 1038, "PER", 9.8893, 0.9998]], [[1047, 1047, "PER", 17.1124, 1.0], [1059, 1059, "PER", 11.0698, 0.9987], [1064, 1064, "PER", 17.5289, 1.0]], [], [], [], [], [[1139, 1139, "PER", 6.2208, 0.9979], [1143, 1143, "PER", 11.5363, 1.0]], []], "predicted_relations": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [[569, 569, 571, 571, "PER-SOC", 14.4532, 1.0]], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}
